Cargando…
The ALK1-Smad1/5-ID1 pathway participates in tumour angiogenesis induced by low-dose photodynamic therapy
Photodynamic therapy (PDT) is an effective and low-invasive tumour therapy. However, it can induce tumour angiogenesis, which is a main factor leading to tumour recurrence and metastasis. Activin receptor-like kinase-1 (ALK1) is a key factor regulating angiogenesis. However, it remains unclear wheth...
Autores principales: | Guo, Xiya, Niu, Yajuan, Han, Wang, Han, Xiaoyu, Chen, Qing, Tian, Si, Zhu, Ying, Bai, Dingqun, Li, Kaiting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019755/ https://www.ncbi.nlm.nih.gov/pubmed/36928315 http://dx.doi.org/10.3892/ijo.2023.5503 |
Ejemplares similares
-
SnoN facilitates ALK1–Smad1/5 signaling during embryonic angiogenesis
por: Zhu, Qingwei, et al.
Publicado: (2013) -
Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers
por: Lee, K T, et al.
Publicado: (2004) -
A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis
por: Zhang, Ying, et al.
Publicado: (2022) -
Author Correction: A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis
por: Zhang, Ying, et al.
Publicado: (2023) -
Author Correction: A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis
por: Zhang, Ying, et al.
Publicado: (2023)